int-2 oncogene amplification and prognosis in node-negative breast carcinoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The int-2 oncogene plays a role in cell growth and development.
• Understanding oncogene amplification is crucial for predicting breast cancer patient outcomes.

Purpose of the Study:

• To investigate the prognostic significance of int-2 oncogene amplification in node-negative breast cancer patients.
• To determine if int-2 amplification is an independent predictor of disease-free survival and local-regional recurrence.

Main Methods:

• Retrospective analysis of 128 node-negative breast cancer patients.
• Assessment of int-2 oncogene amplification, hormone receptor status (ER, PgR), and proliferative activity (3H-thymidine labelling index).
• Disease-free survival and recurrence analysis, adjusted for established prognostic factors.

Main Results:

• Int-2 oncogene amplification was observed in 18% of patients and correlated with hormone receptor status and menopausal status/age.
• Patients with int-2 amplified tumors had significantly lower disease-free survival and higher rates of local-regional recurrence.
• Int-2 amplification remained an independent prognostic factor, even after adjusting for tumor size, steroid receptors, and proliferative rate.

Conclusions:

• Int-2 oncogene amplification is a significant independent prognostic marker in node-negative breast cancer.
• It helps identify patients at higher risk of local-regional recurrence, particularly within subgroups defined by traditional prognostic factors.
• This finding may aid in tailoring treatment strategies for breast cancer patients.